Your browser doesn't support javascript.
loading
BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1).
Williamson, Elizabeth A; Dadmanesh, Farnaz; Koeffler, H Phillip.
Afiliação
  • Williamson EA; Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA. williamsone@cshs.org
Oncogene ; 21(20): 3199-206, 2002 May 09.
Article em En | MEDLINE | ID: mdl-12082635
The p27(Kip1) is a member of the universal cyclin-dependent kinase inhibitor family. Previously, immunochemical analysis of a series of breast cancer cell lines demonstrated a correlation between the expression of p27(Kip1) and the breast cancer susceptibility gene BRCA1. BRCA1 has a number of activities including DNA repair, growth inhibition and as a transcription factor. Here we demonstrate that BRCA1 transactivates expression of p27(Kip1). This transactivation is dependent on the presence of a functional C-terminal transactivation domain. Promoter-deletion analysis identified the presence of a putative BRCA1-responsive element located at position -615 to -511 of the p27(Kip1) promoter. These results suggest that the transcriptional regulation of p27(Kip1) by BRCA1 may be a mechanism for BRCA1- induced growth inhibition.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ativação Transcricional / Proteínas de Ciclo Celular / Proteína BRCA1 / Proteínas Supressoras de Tumor Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2002 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Ativação Transcricional / Proteínas de Ciclo Celular / Proteína BRCA1 / Proteínas Supressoras de Tumor Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2002 Tipo de documento: Article